Intensive care and anesthesia management for HARPOON beating heart mitral valve repair

Patients with severe mitral valve regurgitation secondary to degenerative disease are known to benefit from mitral valve repair surgery. Novel techniques for achieving mitral valve repair on the beating heart have been developed and are being introduced into clinical practice. The HARPOON Beating He...

Full description

Saved in:
Bibliographic Details
Published in:Annals of cardiac anaesthesia 2020-07, Vol.23 (3), p.321-326
Main Authors: Diprose, Paul, Fogg, Katheryn, Pittarello, Demetrio, Gammie, James, D'Ambra, Michael
Format: Article
Language:English
Subjects:
Anesthesia
cardiovascular anaesthesia and surgery
catheter-based coronary and valvular interventions
Catheters
Dexmedetomidine
Esmolol
Feasibility studies
Heart
Heart rate
Heart surgery
Heart valve diseases
image guidance
Intensive care
Mitral valve prolapse
mitral valve repair
Original
Ostomy
Patients
Postoperative period
Pulmonary arteries
Surgeons
transesophageal echocardiography
valvular heart disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with severe mitral valve regurgitation secondary to degenerative disease are known to benefit from mitral valve repair surgery. Novel techniques for achieving mitral valve repair on the beating heart have been developed and are being introduced into clinical practice. The HARPOON Beating Heart Mitral Valve Repair System (MVRS) in recent studies has demonstrated efficacy and safety for the repair of degenerative mitral valve disease on the beating heart. The device uses transoesophageal echocardiographic guidance to implant artificial expanded polytetrafluoroethylene (ePTFE) cords on prolapsed mitral valve leaflets in the beating heart. It requires general anaesthesia and there are specific intensive care and anaesthesia considerations for the safe management of these cases. This article describes the general principles of intensive care and anaesthesia management employed for the initial patients treated with the HARPOON Beating Heart MVRS, the outcomes for these patients, and the potential challenges for the future management of these cases.
ISSN:0971-9784
0974-5181
DOI:10.4103/aca.ACA_200_18